Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.

OBJECTIVES To evaluate predisposing factors such as orofacial manifestations, immunosuppression status and antiretroviral therapy in relation to oral colonization by Candida spp. in Brazilian HIV-infected children and their uninfected siblings in the era of highly active antiretroviral therapy (HAART). METHODS Whole stimulated saliva was collected from 65 HIV-infected children (HIV+) and 40 uninfected siblings (HIV-), followed by assessment of orofacial manifestation, caries indexes and the number of cavitated dentinal carious teeth (CDT). The salivary samples were cultured and the colonies were counted. After which they were identified by sugar assimilation and fermentation (API 20C). Data was analyzed using chi-square, Mann-Whitney, Spearman tests and logistic regression. RESULTS Regarding positive growth, HIV+ presented 80% (52/65) and HIV- 57.5% (23/40) (P = 0.013). Absence of antiretroviral therapy and HAART increased the probability of Candida isolation (P < 0.05). Mean CD4%, immune-status and history of recurrent oral candidiasis (OC) had no influence on Candida isolation. Mixed Candida spp. cultures were observed in HIV+ (40%) and HIV- (52%): C. albicans was more frequently found in both groups, with a higher prevalence in HIV+ (P = 0.05); other non-albicans species were isolated in HIV+ and HIV-. Low prevalence of orofacial manifestations was observed in HIV+ (10.7% of OC). There was an association between means of CDT and Candida growth (P < 0.05) and a positive correlation between number of CDT and Candida cfu-counts in HIV+ and HIV-. Mean CD4% and immune-status had no influence on Candida isolation. Absence of antiretroviral therapy and HAART increased the probability of Candida isolation (P < 0.05). CONCLUSIONS The HIV infected children had a significantly higher prevalence of oral Candida spp. compared to their uninfected siblings. Absence of HAART and presence of dentinal carious teeth increased significantly Candida spp. colonization in these children.

[1]  I. Miziara,et al.  Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  I. P. D. de Souza,et al.  Examining dentinal carious lesions as a predisposing factor for the oral prevalence of Candida spp in HIV-infected children. , 2007, Journal of dentistry for children.

[3]  M. Dierich,et al.  Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells , 2007, Mycoses.

[4]  M. Portela,et al.  Differential Recovery of Candida Species from Subgingival Sites in Human Immunodeficiency Virus-Positive and Healthy Children from Rio de Janeiro, Brazil , 2004, Journal of Clinical Microbiology.

[5]  E. Tacconelli,et al.  Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility. , 2004, FEMS immunology and medical microbiology.

[6]  I. P. D. de Souza,et al.  Pediatric HIV-related oral manifestations: a five-year retrospective study. , 2004, Brazilian oral research.

[7]  C. Koga‐Ito,et al.  Effects of oral environment stabilization procedures on counts of Candida spp. in children. , 2003, Pesquisa odontologica brasileira = Brazilian oral research.

[8]  C. R. Paula,et al.  Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance. , 2003, Pesquisa odontologica brasileira = Brazilian oral research.

[9]  F. Barchiesi,et al.  Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. , 2002, The Journal of antimicrobial chemotherapy.

[10]  M. Ateş,et al.  Prevalence of Candida albicans in oral cavities and root canals of children. , 2002, ASDC journal of dentistry for children.

[11]  C. Shiboski,et al.  Prevalence and classification of HIV-associated oral lesions. , 2002, Oral diseases.

[12]  W. Merz,et al.  Prevalence of yeast among children in Nigeria and the United States. , 2001, Oral microbiology and immunology.

[13]  I. P. D. de Souza,et al.  Oral manifestations related to immunosuppression degree in HIV-positive children. , 2001, Brazilian dental journal.

[14]  M. Jabra-Rizk,et al.  Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. , 2000, Pediatric dentistry.

[15]  L. Patton,et al.  Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. , 2000, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[16]  W. Merz,et al.  Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  A. Telenti,et al.  HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. , 1999, The Journal of investigative dermatology.

[18]  A. Sziegoleit,et al.  Effect of dental treatment and/or local application of amphotericin B to carious teeth on oral colonization by Candida. , 1999, Medical mycology.

[19]  E. Tacconelli,et al.  In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. , 1999, The Journal of infectious diseases.

[20]  M. Schaller,et al.  Effects of the Human Immunodeficiency Virus (HIV) Proteinase Inhibitors Saquinavir and Indinavir on In Vitro Activities of Secreted Aspartyl Proteinases of Candida albicans Isolates from HIV-Infected Patients , 1999, Antimicrobial Agents and Chemotherapy.

[21]  M. Trautmann,et al.  Genotypic relatedness of yeast isolates from women infected with human immunodeficiency virus and their children , 1999, Mycoses.

[22]  C. Flaitz,et al.  Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection. , 1999, The Journal of clinical pediatric dentistry.

[23]  C. Flaitz,et al.  Saliva collection technique for cytologic, microbiologic and viral evaluation in pediatric HIV infection. , 1998, ASDC journal of dentistry for children.

[24]  C. Flaitz,et al.  Detection of fungal organisms in saliva from HIV-infected children: a preliminary cytologic analysis. , 1998, Pediatric dentistry.

[25]  C. Flaitz,et al.  Role of dentinal carious lesions in the pathogenesis of oral candidiasis in HIV infection. , 1998, Journal of the American Dental Association.

[26]  L. Samaranayake,et al.  Association between carriage of oral yeasts, malnutrition and HIV-1 infection among Tanzanian children aged 18 months to 5 years. , 1997, Community dentistry and oral epidemiology.

[27]  J. Phelan.  Oral manifestations of human immunodeficiency virus infection. , 1997, The Medical clinics of North America.

[28]  L. Bjørndal,et al.  A clinical and microbiological study of deep carious lesions during stepwise excavation using long treatment intervals. , 1997, Caries research.

[29]  D. Studen-Pavlovich,et al.  Pediatric HIV infection and its oral manifestations: a review. , 1996, Pediatric dentistry.

[30]  C. Pankhurst,et al.  Use of CHROMagar Candida medium for isolation of yeasts from dental samples , 1995, Journal of clinical microbiology.

[31]  A. Darwazeh,et al.  Oral candidal flora in healthy infants. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[32]  D. Coleman,et al.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. , 1995, Microbiology.

[33]  F. Odds,et al.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species , 1994, Journal of clinical microbiology.

[34]  M. Glick,et al.  Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. , 1994, Oral surgery, oral medicine, and oral pathology.

[35]  W. Coulter,et al.  The use of a concentrated oral rinse culture technique to sample oral candida and lactobacilli in children, and the relationship between candida and lactobacilli levels and dental caries experience: a pilot study. , 2009, International journal of paediatric dentistry.

[36]  I. Thompson,et al.  Oral carriage of Candida in healthy and HIV-seropositive persons. , 1993, Oral surgery, oral medicine, and oral pathology.

[37]  J. Lang,et al.  Asymptomatic oral Candida albicans carriage in HIV-infection: frequency and predisposing factors. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[38]  M. Katz,et al.  Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus infection. , 1993, American journal of diseases of children.

[39]  Powderly Wg.  Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. , 1992 .

[40]  G. M. McCarthy.  Host factors associated with HIV-related oral candidiasis. A review. , 1992, Oral surgery, oral medicine, and oral pathology.

[41]  W. Powderly.  Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. , 1992, AIDS.

[42]  A. Thylstrup,et al.  Results after 3 years of non-operative occlusal caries treatment of erupting permanent first molars. , 1992, Community dentistry and oral epidemiology.

[43]  M. Katz,et al.  Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. , 1991, AIDS.

[44]  A. Thylstrup,et al.  Results after 1 year of non-operative occlusal caries treatment of erupting permanent first molars. , 1991, Community dentistry and oral epidemiology.

[45]  T. Macfarlane,et al.  Caries prevalence and microbiological and salivary caries activity tests in Scottish adolescents. , 1990, Community dentistry and oral epidemiology.

[46]  P. Vilja,et al.  Antimicrobial factors in whole saliva of human infants , 1986, Infection and immunity.

[47]  J. Epstein,et al.  Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects , 1980, Journal of clinical microbiology.

[48]  D. Walker,et al.  The prevalence and intra-oral distribution of Candida albicans in man. , 1980, Archives of oral biology.